| |
| |
|
| Insider
Information: |
Blobel Friedhelm |
| Relationship: |
President, CEO, Direct... |
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
President, CEO, Direct... |
2017-10-13 |
0 |
2007-11-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2012-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,018 |
46,018 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2013-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,018 |
47,036 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2014-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
182,017 |
232,053 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2015-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
80,517 |
212,973 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2015-05-15 |
4 |
AS |
$0.00 |
$0 |
D/D |
(21,700) |
201,273 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-08-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
58,500 |
518,782 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
92,526 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,000 |
148,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
162,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President, CEO, Director |
• • – |
2017-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,000 |
237,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President, CEO, Director |
• • – |
2017-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
387,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2012-06-14 |
4 |
OE |
$1.08 |
$108,000 |
D/D |
100,000 |
147,018 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-08-17 |
4 |
OE |
$1.08 |
$108,000 |
D/D |
100,000 |
588,255 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-23 |
4 |
OE |
$1.08 |
$37,772 |
D/D |
22,807 |
91,591 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-24 |
4 |
OE |
$1.08 |
$27,999 |
D/D |
25,925 |
91,577 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-25 |
4 |
OE |
$1.08 |
$9,577 |
D/D |
8,868 |
95,652 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-02-21 |
4 |
OE |
$1.08 |
$21,790 |
D/D |
20,176 |
106,960 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-02-22 |
4 |
OE |
$1.08 |
$9,937 |
D/D |
9,201 |
95,985 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-02-23 |
4 |
OE |
$1.08 |
$10,584 |
D/D |
9,800 |
96,584 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-02-24 |
4 |
OE |
$1.08 |
$889 |
D/D |
823 |
87,607 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-03-01 |
4 |
OE |
$1.08 |
$9,936 |
D/D |
9,200 |
96,726 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-03-02 |
4 |
OE |
$1.08 |
$4,770 |
D/D |
4,417 |
91,943 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-03-03 |
4 |
OE |
$1.08 |
$30,447 |
D/D |
13,296 |
94,039 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2008-05-20 |
4 |
B |
$1.70 |
$8,500 |
D/D |
5,000 |
15,000 |
2.81 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2009-05-22 |
4 |
B |
$1.71 |
$17,100 |
D/D |
10,000 |
25,000 |
2.81 |
- |
|
173 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
